Print Page  |  Close Window

Overview

Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of over $10 billion in ... Read More >>

Upcoming Events

Thursday, July 25, 2019 9:00 a.m. ET

Q2 2019 Laboratory Corporation of America Holdings Earnings Conference Call

Recent News

06/25/19

LabCorp to Announce Second Quarter Financial Results on July 25, 2019

06/18/19

LabCorp and Mount Sinai Health System Collaborate to Establish Digital and AI-Enabled Pathology Center of Excellence

06/07/19

LabCorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic for Metastatic Breast Cancer

Click Here to view additional press releases

LH (Common)
ExchangeNYSE
Price$168.17
Change Stock is Down 1.24
Data as of 06/26/19 4:00 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.